| 摘要 |
A method of treating a patient suffering from a pathological condition characterized by expression of FAPalpha, the method comprising administering to the patient a therapeutically effective amount of an antibody which specifically binds to FAPalpha. A pharmaceutical composition comprising an antibody which specifically binds to FAPalpha, wherein the antibody is radiolabeled with 131I, 90Y, 186Re, or 188Re, and wherein the antibody has specific activity of from about 0.5 to about 15 mCi/mg, is also provided.
|
